• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Terminology used to describe ductal carcinoma in situ impacts patient preferences

bys25qthea
August 29, 2013
in Chronic Disease, Obstetrics, Oncology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

Image: PD 

1. When the term cancer is used to describe ductal carcinoma in situ (DCIS), significantly more patients chose surgical management compared to medical management or active surveillance. 

2. If DCIS is described as a lesion or as abnormal cells, significantly more women chose active surveillance than medication or surgery. 

Evidence Rating Level: 3 (Average) 

Study Rundown: Ductal carcinoma in situ (DCIS) is a pre-cancerous lesion diagnosed in approximately 50,000 women yearly. Furthermore, despite the frequency at which it is diagnosed it only progresses to cancer in 1 out of every 5 women over the course of up to 40 years. It has been found that the terminology used to deliver the diagnoses to patients influences their treatment decisions. Women in this study were presented with 3 case scenarios that described a case of DCIS using the terms “noninvasive breast cancer”, “breast lesion” or “abnormal cells”.  They were given a number of treatment options with identical outcomes including surgery, medication or watchful waiting.  Significantly more women opted for surgery when the term “cancer” was used in the diagnosis compared to medical management or active surveillance whereas when the word “lesion” or “abnormal cells” were used, more women opted for active surveillance (p <.001). One drawback to this study was that the group of women was otherwise healthy and did not have a diagnosis of DCIS. Therefore, the reaction of women might have been more heavily influenced if they carried the diagnosis of DCIS. Overall, the study suggests that when the word cancer is avoided, there is a higher likelihood of women choosing active surveillance compared to surgery.

Click to read the study in JAMA Internal Medicine

Relevant Reading: Ductal carcinoma in situ: terminology, classification, and natural history

RELATED REPORTS

Rapid CT contrast washout differentiates adrenal adenomas from nonadenomas [Classics Series]

Breast ultrasound sensitive for cancer and carries a low false positive rate [Classics Series]

LCAR-B38M CAR-T cell therapy promising at 4-year follow-up for treatment of refractory multiple myeloma

In-Depth [randomized case-control study]: This study looked at the impact of terminology used for the description of ductal carcinoma in situ on the patient treatment preferences and included 394 women without a history of breast cancer. Three treatment options were given, surgery, medication or active surveillance all with the same outcomes. When the word “cancer” was used, 47% of the women opted for surgery compared to 20% for medication and 33% for active surveillance (p= <.001).  However if the word “cancer” was avoided and the word “lesion” or “abnormal cells” were used, 48% opted for active surveillance in both groups (p= <.001). Also, women with a history of non-breast cancer and higher socioeconomic status were more likely to choose surgery.

By Camellia Banerjee and Brittany Hasty

More from this author: Increased risk of hospitalization following the release of inmates, Early-onset dementia strongly correlated with alcohol intoxication in men 

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

Tags: cancerDCIS
Previous Post

Angiotensin-receptor blockers in diabetic nephropathy [Classics Series]

Next Post

Fluconazole in first trimester not associated with increase in most birth defects

RelatedReports

The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]
Radiology Classics

Rapid CT contrast washout differentiates adrenal adenomas from nonadenomas [Classics Series]

August 5, 2022
The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]
Radiology Classics

Breast ultrasound sensitive for cancer and carries a low false positive rate [Classics Series]

August 3, 2022
The STORM trial: treatment refractory multiple myeloma patients experience response with selinexor
Chronic Disease

LCAR-B38M CAR-T cell therapy promising at 4-year follow-up for treatment of refractory multiple myeloma

July 19, 2022
The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]
Hematology/Oncology Classics

Radiofrequency thermal ablation superior to percutaneous ethanol injection in hepatocellular carcinoma [Classics Series]

June 30, 2022
Next Post
Fluconazole in first trimester not associated with increase in most birth defects

Fluconazole in first trimester not associated with increase in most birth defects

Macitentan better than placebo for preventing progression of pulmonary arterial hypertension [SERAPHIN Trial]

Macitentan better than placebo for preventing progression of pulmonary arterial hypertension [SERAPHIN Trial]

Rituximab linked with reduced chronic immune disease following stem cell transplantation

Rituximab linked with reduced chronic immune disease following stem cell transplantation

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Ciprofol comparable to propofol for general anesthesia induction for gynecological surgery
  • Moderate-intensity statin plus ezetimibe is non-inferior to high-intensity statin monotherapy
  • Type of compensation model influences gender pay gap in primary care
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.